$0.28
+0.00 (+1.66%)
Open$0.28
Previous Close$0.27
Day High$0.29
Day Low$0.27
52W High$1.45
52W Low$0.22
Volume—
Avg Volume1.04M
Market Cap13.50M
P/E Ratio—
EPS$-4.16
SectorN/A
Analyst Ratings
Strong Buy
8 analysts
Price Target
+5,567.0% upside
Current
$0.28
$0.28
Target
$15.59
$15.59
$14.04
$15.59 avg
$21.75
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 19.22M | 20.30M | 17.77M |
| Net Income | 1.18M | 1.16M | 1.21M |
| Profit Margin | 6.1% | 5.7% | 6.8% |
| EBITDA | 2.01M | 2.27M | 2.16M |
| Free Cash Flow | 1.07M | 1.22M | 952.2K |
| Rev Growth | +20.2% | +6.7% | +16.3% |
| Debt/Equity | 0.67 | 0.58 | 0.78 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.03 | +34.07% | — | 1.41B |
| PICS | Pics Nv | $11.49 | +0.70% | 6.6 | 1.48B |
| DMII | Drugs Made In America Acquis | $10.13 | +0.10% | 75.2 | 645.28M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.75 | +0.55% | 35.5 | 336.67M |
| CEPF | Cantor Equity Partners-Cl A | $10.39 | +0.14% | 57.9 | 595.50M |